Experimental drugs in randomized controlled trials for long-COVID: what's in the pipeline? A systematic and critical review
Introduction Over three years have passed since the emergence of coronavirus disease
2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome …
2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome …
[HTML][HTML] TLR3 forms a highly organized cluster when bound to a poly (I: C) RNA ligand
CS Lim, YH Jang, GY Lee, GM Han, HJ Jeong… - Nature …, 2022 - nature.com
Abstract Toll-like Receptor 3 (TLR3) initiates a potent anti-viral immune response by binding
to double-stranded RNA ligands. Previous crystallographic studies showed that TLR3 forms …
to double-stranded RNA ligands. Previous crystallographic studies showed that TLR3 forms …
[HTML][HTML] Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus …
Y Liu, T Lu, C Li, X Wang, F Chen, L Yue… - Frontiers in …, 2023 - frontiersin.org
Introduction Since its outbreak in December 2019, SARS-CoV-2 has spread rapidly across
the world, posing significant threats and challenges to global public health. SARS-CoV-2 …
the world, posing significant threats and challenges to global public health. SARS-CoV-2 …
[HTML][HTML] The impact of COVID-19 Infection in Cancer 2020–2021
G D'Orazi, M Cirone - Cancers, 2022 - mdpi.com
Cancers | Free Full-Text | The Impact of COVID-19 Infection in Cancer 2020–2021
Next Article in Journal C-Reactive Protein Pretreatment-Level Evaluation for Ewing’s …
Next Article in Journal C-Reactive Protein Pretreatment-Level Evaluation for Ewing’s …
[HTML][HTML] Противовирусная активность лекарственного препарата на основе РНК двуспиральной натриевой соли в отношении SARS-CoV-2 in vitro
ГМ Игнатьев, ЕЮ Шустова, ЕА Рогожина… - БИОпрепараты …, 2023 - cyberleninka.ru
Актуальность. Активация механизмов врожденного иммунитета на ранних фазах
развития инфекции COVID-19 и, как следствие, последующая индукция продукции …
развития инфекции COVID-19 и, как следствие, последующая индукция продукции …
[HTML][HTML] Review of COVID-19 therapeutics by mechanism: from discovery to approval
HS Choi, AY Choi, JB Kopp, CA Winkler… - Journal of Korean …, 2024 - ncbi.nlm.nih.gov
The global research and pharmaceutical community rapidly mobilized to develop treatments
for coronavirus disease 2019 (COVID-19). Existing treatments have been repurposed and …
for coronavirus disease 2019 (COVID-19). Existing treatments have been repurposed and …